Eton Pharmaceuticals (ETON) Other Accumulated Expenses (2023 - 2025)

Eton Pharmaceuticals has disclosed Other Accumulated Expenses across 3 years of filings, most recently posting $675000.0 for Q1 2025.

• Other Accumulated Expenses for Q1 2025 came in at $675000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2025 was $675000.0 (changed N/A YoY), and the FY2023 annual result was $5.4 million, changed N/A from the prior year.
• Other Accumulated Expenses came in at $675000.0 for Q1 2025 at Eton Pharmaceuticals, down from $4.9 million in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $5.4 million in Q4 2023 to a low of $675000.0 in Q1 2025.
• The 3-year median for Other Accumulated Expenses is $4.9 million (2024), against an average of $3.6 million.